Concepedia

Carlos R. Gil Del Alcazar

CR

Statistics

Publications

8

Citations

726

H-Index

8

Active since

2012

Affiliations

The University of Texas Southwestern Medical Center(Current)

Dana-Farber Cancer Institute

Harvard University

Harvard Stem Cell Institute

Brigham and Women's Hospital

Carlos R. Gil Del Alcazar is an author at The University of Texas Southwestern Medical Center specializing in oncology, medicine, and molecular oncology.

ORCID

Publications per year

2012–2022

8

Publications

8

Immune Escape in Breast Cancer During <i>In Situ</i> to Invasive Carcinoma Transition

Carlos R. Gil Del Alcazar, Sung Jin Huh, Muhammad B. Ekram et al. · Cancer Discovery · 2017 · 242 citations · Full text

, , +17

Inhibition of DNA Double-Strand Break Repair by the Dual PI3K/mTOR Inhibitor NVP-BEZ235 as a Strategy for Radiosensitization of Glioblastoma

Carlos R. Gil Del Alcazar, Molly Catherine Hardebeck, Bipasha Mukherjee et al. · Clinical Cancer Research · 2013 · 170 citations · Full text

, , +17

Phase II study of ruxolitinib, a selective JAK1/2 inhibitor, in patients with metastatic triple-negative breast cancer

Daniel G. Stover, Carlos R. Gil Del Alcazar, Jane Brock et al. · npj Breast Cancer · 2018 · 150 citations · Full text

, , +16

Augmented HR Repair Mediates Acquired Temozolomide Resistance in Glioblastoma

Carlos R. Gil Del Alcazar, Pavlina Krasimirova Todorova, Amyn A. Habib et al. · Molecular Cancer Research · 2016 · 69 citations · Full text

, , +16

Genomic Alterations during the <i>In Situ</i> to Invasive Ductal Breast Carcinoma Transition Shaped by the Immune System

Anne Trinh, Carlos R. Gil Del Alcazar, Sachet A. Shukla et al. · Molecular Cancer Research · 2020 · 38 citations · Full text

, , +17

1–5 of 8